These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27256566)

  • 1. mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-α.
    Cao G; Wang Q; Li G; Meng Z; Liu H; Tong J; Huang W; Liu Z; Jia Y; Wei J; Chi H; Yang H; Zhao L; Wu Z; Hao J; Yin Z
    J Leukoc Biol; 2016 Nov; 100(5):1181-1189. PubMed ID: 27256566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally activated V gamma 4 gamma delta T cells play a protective role in tumor immunity through expression of eomesodermin.
    He W; Hao J; Dong S; Gao Y; Tao J; Chi H; Flavell R; O'Brien RL; Born WK; Craft J; Han J; Wang P; Zhao L; Wu J; Yin Z
    J Immunol; 2010 Jul; 185(1):126-33. PubMed ID: 20525896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory role of Vγ1 γδ T cells in tumor immunity through IL-4 production.
    Hao J; Dong S; Xia S; He W; Jia H; Zhang S; Wei J; O'Brien RL; Born WK; Wu Z; Wang P; Han J; Hong Z; Zhao L; Yin Z
    J Immunol; 2011 Nov; 187(10):4979-86. PubMed ID: 21987661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
    Story JY; Zoine JT; Burnham RE; Hamilton JAG; Spencer HT; Doering CB; Raikar SS
    Cytotherapy; 2021 Jan; 23(1):12-24. PubMed ID: 33168453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells.
    Dao V; Liu Y; Pandeswara S; Svatek RS; Gelfond JA; Liu A; Hurez V; Curiel TJ
    Cancer Res; 2016 Oct; 76(20):5970-5982. PubMed ID: 27569211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cells.
    Dokouhaki P; Schuh NW; Joe B; Allen CA; Der SD; Tsao MS; Zhang L
    Eur J Immunol; 2013 Dec; 43(12):3175-82. PubMed ID: 24019170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo.
    Kabelitz D; Wesch D; Pitters E; Zöller M
    J Immunol; 2004 Dec; 173(11):6767-76. PubMed ID: 15557170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells
    Wang Z; Wang Z; Li S; Li B; Sun L; Li H; Lin P; Wang S; Teng W; Zhou X; Ye Z
    Front Immunol; 2018; 9():1239. PubMed ID: 29910819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the opposing roles of different gamma delta T cell subsets in macrophage homeostasis.
    Tramonti D; Andrew EM; Rhodes K; Newton DJ; Carding SR
    Eur J Immunol; 2006 Jul; 36(7):1729-38. PubMed ID: 16783854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.
    Peipp M; Wesch D; Oberg HH; Lutz S; Muskulus A; van de Winkel JGJ; Parren PWHI; Burger R; Humpe A; Kabelitz D; Gramatzki M; Kellner C
    Scand J Immunol; 2017 Oct; 86(4):196-206. PubMed ID: 28708284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway.
    Chen X; Zhang Z; Bi Y; Fu Z; Gong P; Li Y; Yu Q; Jia A; Wang J; Xue L; Yang H; Liu G
    J Leukoc Biol; 2016 Dec; 100(6):1349-1362. PubMed ID: 27462101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of γδ T cells in α-galactosylceramide-mediated immunity.
    Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ
    J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity.
    Berezhnoy A; Castro I; Levay A; Malek TR; Gilboa E
    J Clin Invest; 2014 Jan; 124(1):188-97. PubMed ID: 24292708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gammadelta T-cell clones from intestinal intraepithelial lymphocytes inhibit development of CTL responses ex vivo.
    Kapp JA; Kapp LM; McKenna KC; Lake JP
    Immunology; 2004 Feb; 111(2):155-64. PubMed ID: 15027900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
    Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
    J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D.
    Wang Z; Guo L; Song Y; Zhang Y; Lin D; Hu B; Mei Y; Sandikin D; Liu H
    Cancer Immunol Immunother; 2017 Apr; 66(4):537-548. PubMed ID: 28184969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.